120 related articles for article (PubMed ID: 20116116)
1. Validation of functional imaging with pathology for tumor delineation in the prostate.
Groenendaal G; Moman MR; Korporaal JG; van Diest PJ; van Vulpen M; Philippens ME; van der Heide UA
Radiother Oncol; 2010 Feb; 94(2):145-50. PubMed ID: 20116116
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
3. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
Hambrock T; Fütterer JJ; Huisman HJ; Hulsbergen-vandeKaa C; van Basten JP; van Oort I; Witjes JA; Barentsz JO
Invest Radiol; 2008 Oct; 43(10):686-94. PubMed ID: 18791410
[TBL] [Abstract][Full Text] [Related]
4. Pathologic validation of a model based on diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging for tumor delineation in the prostate peripheral zone.
Groenendaal G; Borren A; Moman MR; Monninkhof E; van Diest PJ; Philippens ME; van Vulpen M; van der Heide UA
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e537-44. PubMed ID: 22197085
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
[TBL] [Abstract][Full Text] [Related]
6. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
7. MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
Scherr MK; Seitz M; Müller-Lisse UG; Ingrisch M; Reiser MF; Müller-Lisse UL
Eur J Radiol; 2010 Dec; 76(3):359-66. PubMed ID: 20471189
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
9. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients.
Groenendaal G; van den Berg CA; Korporaal JG; Philippens ME; Luijten PR; van Vulpen M; van der Heide UA
Radiother Oncol; 2010 May; 95(2):185-90. PubMed ID: 20231041
[TBL] [Abstract][Full Text] [Related]
11. Diffusion tensor magnetic resonance imaging of prostate cancer.
Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology.
Isebaert S; Van den Bergh L; Haustermans K; Joniau S; Lerut E; De Wever L; De Keyzer F; Budiharto T; Slagmolen P; Van Poppel H; Oyen R
J Magn Reson Imaging; 2013 Jun; 37(6):1392-401. PubMed ID: 23172614
[TBL] [Abstract][Full Text] [Related]
13. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features.
Langer DL; van der Kwast TH; Evans AJ; Plotkin A; Trachtenberg J; Wilson BC; Haider MA
Radiology; 2010 May; 255(2):485-94. PubMed ID: 20413761
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
[TBL] [Abstract][Full Text] [Related]
16. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.
Puech P; Potiron E; Lemaitre L; Leroy X; Haber GP; Crouzet S; Kamoi K; Villers A
Urology; 2009 Nov; 74(5):1094-9. PubMed ID: 19773038
[TBL] [Abstract][Full Text] [Related]
18. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging.
Miao H; Fukatsu H; Ishigaki T
Eur J Radiol; 2007 Feb; 61(2):297-302. PubMed ID: 17085002
[TBL] [Abstract][Full Text] [Related]
20. Editorial comment on: role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Hara N
Eur Urol; 2008 Sep; 54(3):598-9. PubMed ID: 18226440
[No Abstract] [Full Text] [Related]
[Next] [New Search]